Vijaya Diagnostic Centre peers

·Pharma & HealthChart ›

Companies like Vijaya Diagnostic Centrelatest year

Vijaya Diagnostic CentreVIJAYA · FY26 · this company
Market cap₹15,066
P/E87.10×
Sales growth+22.8%
ROE19.7%
Thyrocare TechnologiesTHYROCARE · FY26
Open ›
Market cap₹8,205
P/E50.19×
Sales growth+25.1%
ROE28.8%
Metropolis HealthcareMETROPOLIS · FY26
Open ›
Market cap₹11,483
P/E60.27×
Sales growth+16.6%
ROE13.4%
Dr. Lal Path LabsLALPATHLAB · FY26
Open ›
Market cap₹32,040
P/E63.22×
Sales growth+19.1%
ROE21.6%

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

VIJAYA₹1,464.20

Vijaya Diagnostic Centre Ltd.

· Pharma & Health
₹ CrorePeersTHYROCAREMETROPOLISLALPATHLABRAINBOWPOLYMEDPFIZERONESOURCEKIMSMcap ₹15,066 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
VIJAYA
FY26
THYROCARE
FY26
METROPOLIS
FY26
LALPATHLAB
FY26
Peer
Average
Valuation — at last close
P/E87.10×◆ 50.19×60.27×63.22×57.89× +50%
P/B15.74×14.02×◆ 7.59×12.77×11.46× +37%
EV/EBITDA43.88×30.48×◆ 28.22×39.29×32.66× +34%
Market Cap₹15,066 Cr₹8,205 Cr₹11,483 Cr₹32,040 Cr₹17,243 Cr -13%
Growth
Revenue CAGR 3Y◆ 21.03%16.33%12.75%11.06%13.38% +57%
Revenue CAGR 5Y◆ 16.66%10.88%10.52%11.81%11.07% +50%
Net Income CAGR 3Y26.62%◆ 36.27%10.06%28.35%24.89% +7%
Revenue YoY (latest Q)22.83%◆ 25.07%16.62%19.10%20.26% +13%
Net Income YoY (latest Q)◆ 37.61%-68.17%25.72%27.24%-5.07% +842%
Profitability
EBITDA Margin◆ 41.38%31.61%24.36%28.32%28.10% +47%
Net Income Margin◆ 21.24%19.64%11.62%18.45%16.57% +28%
Return on Common Equity19.74%◆ 28.80%13.36%21.57%21.24% -7%
Return on Capital Employed19.65%◆ 33.68%15.82%24.78%24.76% -21%
Return on Assets12.44%◆ 22.62%9.55%17.39%16.52% -25%
Credit & Quality
Total Debt/Equity◆ 0.00×0.00×0.01×0.00×0.00× -100%
Interest Coverage7.38×◆ 72.66×10.88×27.22×36.92× -80%
Scale — latest FY
Revenue / Total Income₹814 Cr₹829 Cr₹1,646 Cr₹2,763 Cr₹1,746 Cr -53%
Net Income₹173 Cr₹163 Cr₹191 Cr₹510 Cr₹288 Cr -40%
Total Assets₹1,507 Cr₹747 Cr₹2,138 Cr₹3,146 Cr₹2,010 Cr -25%
EPS₹16.81₹10.27₹9.19₹30.24₹16.57 +1%
Book Value per Share₹93.02₹36.78₹72.98₹149.65₹86.47 +8%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.